Why Your Body Isn’t Converting T4 to T3 | The Terrain Reason

The Labs Improved. You Didn’t.

You did everything right. You fought for the labs and pushed past the doctor who said your TSH was “fine.” The prescription came — levothyroxine, maybe Synthroid — taken on an empty stomach, thirty minutes before coffee, every morning for months.

And you’re still exhausted: hair still thinning, brain still stalling mid-sentence, body running on dial-up. The labs improved. You didn’t.

Your medication is doing exactly what it does by design: replace a hormone. The problem is that hormone replacement was never the whole story; the rest of that story lives in a single enzymatic step most doctors never check.

If This Is You

If you’ve been on levothyroxine for months and are still exhausted, still losing hair, still foggy — despite labs that are now “in range”…
If your doctor says your TSH is fine but nothing about how you feel is fine…
If you’ve had your dose increased and felt better briefly — then felt exactly the same again three months later…
If you’ve researched T3, reverse T3, and desiccated thyroid and your provider won’t engage with any of it…

Your medication replaced a hormone. It never had instructions for the conversion step — or for the terrain that’s blocking it.

The Conversion Problem

Your thyroid gland makes mostly T4 — a storage hormone, a precursor. Your body has to convert that T4 into T3, the active form that actually drives metabolism, energy, and cognitive function. Levothyroxine is synthetic T4, which gives your body more raw material to work with.

What it doesn’t do: fix why your body isn’t converting T4 to T3.

T4-to-T3 conversion depends on terrain — the underlying physiological conditions your thyroid operates inside. When terrain is compromised, your body shunts T4 into reverse T3 (rT3) instead of active T3. Reverse T3 is the brake your peripheral tissues apply when the system cannot afford full throttle, a deiodinase-level decision rather than a thyroid one. The prescription filled the tank. The engine can’t burn the fuel.

You can have a “normal” TSH, adequate T4 levels, and still be functionally hypothyroid at the cellular level.

Where Conversion Breaks Down

The terrain culprits are specific and measurable.

Chronic stress physiology. Sustained HPA activation drives cortisol output that suppresses the thyroid axis and the deiodinase enzymes responsible for T4-to-T3 conversion. Your body reads prolonged stress as a signal to conserve energy, and it does — by throttling metabolism at the conversion step. More medication doesn’t override this signal. It gives you more T4 to shunt into rT3.

Systemic inflammation. Inflammatory cytokines directly block T4-to-T3 conversion. If you have gut dysbiosis, insulin resistance, chronic infections, or unresolved immune activation, these conditions compromise your conversion pathway before the levothyroxine even hits the bloodstream.

Insulin resistance. Insulin resistance suppresses T4-to-T3 conversion through both direct mechanisms and the inflammatory burden it carries, which means it can compound the problem even when inflammation isn’t the primary driver. The woman who cleaned up her diet, added strength training, and is still watching the scale move the wrong direction is often carrying insulin resistance that’s been compounding the conversion problem the entire time, before anyone thought to check it.

Gut absorption. The small intestine absorbs levothyroxine. Celiac disease and chronic PPI use are among the better-documented culprits, but any condition disrupting small intestinal function can reduce how much levothyroxine actually reaches the bloodstream, and the losses can be substantial. You may be absorbing a fraction of your prescribed dose and compensating by running harder on a system that’s already depleted.

None of these variables appear on a standard thyroid panel, which explains exactly what happens when you report that the medication isn’t working.

Why Your Doctor Keeps Adjusting the Dose

When you report that you’re still symptomatic, the standard response is: increase the dose, or switch to a different formulation. Sometimes that helps briefly — until the fatigue creeps back, new symptoms appear (anxiety, palpitations, insomnia), and you’re caught between too much and not enough.

Titrating a hormone without addressing the terrain it operates inside produces a predictable pattern: the dose gets adjusted, the symptoms shift, the window closes. Conversion capacity is the variable that matters most; it’s downstream of your nervous system state, your inflammatory load, your metabolic flexibility, and your gut integrity.

Dose adjustment isn’t wrong: sometimes more T4 is exactly what’s needed. But when conversion is impaired, you’re optimizing one variable while the actual bottleneck sits upstream — and that bottleneck has a clinical signature worth reading.

What the Signal Means

High rT3 with normal or low FT3 is survive-first signaling. Your body is saying: the load exceeds what I can safely sustain at full metabolic output. A body conserving metabolic output under genuine threat is doing its job — the down-regulation is the intelligence. More hormone doesn’t change that calculus.

Changing the calculus requires addressing the nervous system load before optimizing the thyroid protocol: stabilizing blood sugar so insulin stops sabotaging conversion, reducing the inflammatory burden so deiodinase enzymes can do their job, restoring gut function so the medication you’re already taking can actually absorb.

One legitimate response to impaired conversion is bypassing it entirely: desiccated thyroid (Armour) and synthetic T3 (cytomel) deliver active T3 directly, sidestepping the conversion step that’s failing. Whether that’s appropriate depends on your full picture, but it belongs in the conversation — especially when you’ve optimized T4 monotherapy and you’re still symptomatic.

The prescription addressed the gland. It never had instructions for the ground it sits on.

What Working With Me Looks Like For This

In my practice, thyroid cases that have plateaued on T4 monotherapy are assessed as terrain problems before medication problems. The intake maps HPA axis load, inflammatory markers, gut function, blood sugar patterns, and the structural bracing that drives cortisol suppression of deiodinase enzymes. Hands-on, the work addresses thoracic and cervical bracing that sustains sympathetic dominance — because cortisol suppression of T4-to-T3 conversion is one of the most consistent effects of chronic threat physiology, and it can’t be corrected at the prescription level. The SWIM terrain lens maps which of the four conversion blockers is loudest; the Vital Clarity Code sequences what to address before adjusting any protocol.

My practice is in Sandpoint, Idaho — in-person for North Idaho women, virtual for those further out.

A Vital Signal Check decodes what your terrain is doing to your conversion — 45 minutes before adjusting any protocol. If structural bracing is the primary driver, a Midlife Body Reset addresses those holding patterns directly.

Why Your Body Isn’t Converting T4 to T3: Common Questions

Why isn’t my T4 converting to T3? T4-to-T3 conversion depends on deiodinase enzymes that are directly suppressed by cortisol, inflammatory cytokines, and insulin resistance — the same terrain variables that drive most midlife fatigue presentations. When chronic stress physiology is running, the body shunts T4 into reverse T3 (rT3) instead of active T3 as a metabolic brake. This happens at the cellular level regardless of TSH or serum T4 levels, which is why labs can look “normal” while symptoms remain significant.

What is reverse T3 and why does it matter? Reverse T3 is an inactive metabolite of T4 that competes with active T3 for the same cellular receptors. When the body shunts T4 into rT3 rather than active T3, it effectively blocks thyroid action at the cellular level even when circulating levels appear adequate. High rT3 with low-normal FT3 is a classic sign of survive-first signaling — the body conserving metabolic output under load. Standard thyroid panels don’t include rT3, which is why this pattern frequently goes undetected.

Should I take T3 instead of T4? For some women with documented conversion impairment, yes — adding T3 (cytomel) or switching to desiccated thyroid (which contains both T3 and T4) bypasses the conversion step that’s failing. But this doesn’t address the terrain blocking conversion in the first place. Women who add T3 without addressing stress physiology, inflammation, or gut function often find they need escalating doses for diminishing returns. Terrain stabilization first tends to improve both conversion efficiency and medication tolerance.

If you’ve done the protocols, adjusted the dose, and your body still isn’t cooperating — book a Vital Signal Check. Forty-five minutes to decode what your body is actually signaling and why the medication isn’t landing.